AI
Anthony P Bihl III
Interim CEODirector

Anthony P Bihl III insider trades: Bioventus (BVS) stock purchases

Interim CEO, Bioventus Last trade Aug 18, 2023 49 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2008
6
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Anthony reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 18, 2023BVS↑ Buy$110K
Aug 18, 2023BVS↑ Buy$55K
May 23, 2023BVS↑ Buy$291K
May 17, 2022SONX↑ Buy$58K
May 16, 2022SONX↑ Buy$43K
May 13, 2022SONX↑ Buy$40K
Nov 2, 2021SONX↑ Buy$192K
Nov 25, 2020VIVO↑ Buy$88K
May 6, 2019NVTR↑ Buy$87K
Aug 19, 2008AMMD↑ Buy$89K
Aug 14, 2008AMMD↑ Buy$91K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BVS insiders

Open-market trades in the last 12 months

About Anthony P Bihl III's insider trades

Anthony P Bihl III is Interim CEO at Bioventus (BVS). Since Aug 14, 2008, Anthony has reported 11 open-market purchases worth $1.1M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (21 filings), option exercises (15 filings), shares returned to the company (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BVS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.